Metastatic Malignant Solid Neoplasm: Clinical Trials

5 trials for Metastatic Malignant Solid Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 1 completed, 1 terminated. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Active not recruiting 3, Completed 1, Terminated 1
Phase 21Active not recruiting 1

Follow Metastatic Malignant Solid Neoplasm: new trials by email Literature Review of Metastatic Malignant Solid Neoplasm trials Research Report on Metastatic Malignant Solid Neoplasm

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
Best Practice, Biospecimen Collection, Bone Metastases Treatment - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm
Phase 3Active not recruitingNRG Oncology2802025-05-072026-08-17
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Computed Tomography, Fractionated Stereotactic Radiation Therapy, Magnetic Resonance Imaging - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3Active not recruitingNRG Oncology2742024-12-122026-09-14
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma
Phase 3TerminatedNRG Oncology192021-08-052026-05-20
Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer
Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center1002019-03-302026-08-11
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Apixaban - Cerebral Vein Thrombosis, Deep Vein Thrombosis
Phase 3CompletedAcademic and Community Cancer Research United3702017-07-142025-05-18

Narrower conditions

Neoplasm Metastasis (5)  ·  Brain Neoplasms (2)  ·  Breast Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Renal Cell (2)  ·  Lung Neoplasms (2)  ·  Melanoma (2)  ·  Gastrointestinal Neoplasms (1)  ·  Hematologic Neoplasms (1)  ·  Intracranial Thrombosis (1)  ·  Pulmonary Embolism (1)  ·  Small Cell Lung Carcinoma (1)  ·  Venous Thrombosis (1)

Broader conditions

Neoplasms (5)  ·  Neoplastic Processes (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Lung Diseases (3)  ·  Neoplasms by Site (3)  ·  Nervous System Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Adenocarcinoma (2)  ·  Breast Diseases (2)  ·  Bronchial Neoplasms (2)  ·  Carcinoma (2)  ·  Carcinoma, Bronchogenic (2)

Interventions

Magnetic Resonance Spectroscopy (3)  ·  Radiosurgery (3)  ·  Specimen Handling (2)  ·  Memantine (1)  ·  Observation (1)  ·  Practice Guidelines as Topic (1)  ·  Radiation (1)  ·  Standard of Care (1)  ·  Waiting Lists (1)  ·  Watchful Waiting (1)  ·  apixaban (1)

Sponsors

NRG Oncology (3)  ·  Academic and Community Cancer Research United (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (5)  ·  Canada (3)  ·  Hong Kong (2)  ·  Ireland (1)

Top investigators

Erin F Gillespie (1)  ·  Robert D McBane (1)  ·  Rupesh R Kotecha (1)  ·  Sriram Yennu (1)  ·  Vinai Gondi (1)

Results publications

PMID 31606897, PMID 38537780, PMID 41825136

NIH funding

U10CA180868 (2), P30CA015083 (1), UG1CA189867 (1)